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Thermodynamic studies on ligand–protein binding have become increasingly important in the process of drug design.
In combinationwith structural data andmolecular dynamics simulations, thermodynamic studies provide relevant infor-
mation about the mode of interaction between compounds and their target proteins and therefore build a sound basis
for further drug optimization. Using the example of histone deacetylases (HDACs), particularly the histone deacetylase
like amidohydrolase (HDAH) from Bordetella/Alcaligenes, a novel sensitive competitive ﬂuorescence resonance energy
transfer-based binding assay was developed and the thermodynamics of interaction of both ﬂuorescent ligands and
inhibitors to histone deacetylase like amidohydrolase were investigated. The assay consumes only small amounts of
valuable target proteins and is suitable for fast kinetic and mechanistic studies as well as high throughput screening
applications. Binding afﬁnity increased with increasing length of aliphatic spacers (n=4–7) between the hydroxamate
moiety and the dansyl head group of ligand probes. Van’t Hoff plots revealed an optimum in enthalpy contribution
to the free energy of binding for the dansyl-ligand with hexyl spacer. The selectivity in the series of dansyl-ligands
against human class I HDAC1 but not class II HDACs 4 and 6 increased with the ratio ofΔH0/ΔG0. The data clearly empha-
size the importance of thermodynamic signatures as useful general guidance for the optimization of ligands or rational
drug design. Copyright © 2014 John Wiley & Sons, Ltd.
Additional supporting information may be found in the online version of this article at the publisher’s web site.
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INTRODUCTION
Thermodynamic studies on ligand–protein binding have
become increasingly important in the process of drug design
in recent years (Chaires, 2008; Ladbury et al., 2009; Kawasaki
and Freire, 2011).
Understanding the nature of molecular interactions requires
structural studies and a thorough thermodynamic dissection of
the forces that drive the recognition process. Molecular recogni-
tion through non-covalent binding includes both enthalpic and
entropic contributions, with such binding processes governed
by hydrogen bonding, metal coordination, hydrophobic interac-
tions, and other less frequent interactions like halogen bonds or
cation-π-interactions as well as solvation effects and dynamic
structural changes of interacting ligand and protein (Chaires,
2008; Bissantz et al., 2010; Bronowska, 2011). In general, a
negative free energy of binding (ΔG0) indicates a spontaneous
process and in the case of ligand–protein binding deﬁnes the
ratio of bound complex concentration and the concentrations
of free binding partners at chemical equilibrium. Consequently,
ΔG0 values can be calculated from dissociation constants (Kd)
according to
ΔG0 ¼ RT ln Kdð Þ (1)
Furthermore, ΔG0 is composed of an enthalpic term (ΔH0) and
an entropic term (TΔS0) at constant pressure:
ΔG0 ¼ ΔH0  TΔS0 (2)
The balance between enthalpic and entropic components is
called the thermodynamic signature of a ligand or drug with re-
spect to its target protein. Traditionally, most drugs have been
optimized with respect to afﬁnity and therefore binding free
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energy. This practice has been recently highlighted by Stahl et al.
who claimed that “optimizing for free energy is still the only
viable approach to structure-based design” because enthalpic
and entropic contributions to binding depend highly on the
interaction system under investigation (Bissantz et al., 2010).
However, it is well known that over the course of traditional lead
optimization, improvements in compound potency through the
addition of hydrophobic moieties to the core of the lead
structure usually result from an entropic contribution to binding.
Such an approach has serious drawbacks, including unfavorable
effects on the physiochemical properties of the ligand and a loss
in drug selectivity, because binding is principally driven by the
non-speciﬁc hydrophobic effect. On the other hand, the design
of optimal non-covalent interactions between a ligand and a
protein to improve ΔH0 is exceptionally difﬁcult. Ladbury et al.
(2009) have highlighted the value of enthalpy data for aiding
lead structure optimization. The authors exempliﬁed their
approach through retroperspective analysis of the development
of the statin class of drugs, which inhibit the enzyme 3-hydroxy-
3-methylglutaryl coenzyme A reductase, and through analysis of
HIV protease inhibitors. In both cases, best-in-class compounds
were associated with improved ΔH0 (more negative) contri-
butions. The value of enthalpy-driven optimization was also
demonstrated by studies on inhibitors of plasmepsin II, a hemo-
globin-degrading enzyme that is a key component in the life
cycle of the Plasmodium parasites responsible for malaria (Ruben
et al., 2006). Plotting the binding constants of 71 inhibitors
versus the ratio ΔH0/ΔG0 revealed a so-called enthalpy funnel,
in which the enthalpy/entropy combinations narrowed as afﬁn-
ity increased. The optimal balance in this particular molecular
system arose when the free energy partitioned to an appro-
ximate one third enthalpic and two thirds entropic contribution.
The heat of interaction (ΔH0) can be either directly measured
using isothermal titration calorimetry or calculated from linear ﬁts
to binding free energy data as a function of temperature
according to equation 2. The assumption that ΔH0 is constant over
relatively small ranges of temperatures, for example, 10–20 K, is
justiﬁed in many protein–ligand systems. Another important
aspect in interpreting enthalpic and entropic contributions to
ΔG0 is the molecular dynamics (MD) of ﬂexible protein–ligand
complexes. Non-covalent binding can be positively cooperative,
for example, if the structure of the target protein is tightened
upon the formation of additional interactions, (Williams et al.,
2003) with bonding opposing motion and vice versa. Therefore,
in combination with structural data and MD simulations, ther-
modynamic studies are supposed to provide relevant informa-
tion about the mode of interaction between compounds and
target proteins.
In this study, we investigated the thermodynamics of ligand
binding to HDAH from Bordetella/Alcaligenes (Hildmann et al.,
2004). HDAH is structurally closely related to human HDACs
(Nielsen et al., 2005). HDAH and the second catalytic domain
of human HDAC6 share an identity of 35%. Indeed, a large
amount of data has been accumulated that prove that HDAH
serves as a good model for HDACs, particularly for HDAC6. This
fact is among others reﬂected by the similar selectivities for
substrates and inhibitors of these enzymes (Hildmann et al.,
2006; Riester et al., 2009). HDACs are widely distributed and dif-
ferently expressed in different cell types. There are 18 isoforms
of human HDACs that are divided into three classes of zinc
cation dependent enzymes and one class, the sirtuins, which
require NAD+ as coenzyme for their activity. Class I consist of
isoforms HDAC1, HDAC2, HDAC3, and HDAC8; class II is
subdivided into class IIa including HDAC4, HDAC5, HDAC7,
and HDAC9, which shuttle between nucleus and cytoplasm in
a highly regulated way, and class IIb enzymes HDAC6 and
HDAC10, which in contrast to all other HDACs contain two
catalytic domains. Class IIa and class IIb exhibit completely
different substrate speciﬁcities, with class IIb HDACs having a
preference for cytosolic substrates, for example, α-tubulin,
HSP90, or cortactin for HDAC6 (Aldana-Masangkay and
Sakamoto, 2011). Based on multiple sequence alignments,
HDAC11 was assigned to class IV. HDACs and their antagonistic
opponents, histone acetyl transferases, play pivotal roles in
cellular differentiation, proliferation, apoptosis, and the
pathogenesis of malignant diseases through balancing the
acetylation status of histones and many non-histone proteins
(Ropero and Esteller, 2007; Marks, 2010). While initially, these
enzymes were only recognized to deacetylate N-terminal lysine
residues of histones, they were subsequently identiﬁed to have
many cytosolic substrates, underlining the broad functionality
of HDACs in controlling many cellular processes (Peng and
Seto, 2011). A wealth of experimental data has been collected
over the last decade proving HDACs to be highly relevant can-
cer targets (Ropero and Esteller, 2007; Shankar and Srivastava,
2008). Consequently, much effort has been invested in identify-
ing HDAC inhibitors and their subsequent development into
drugs against certain types of cancer. The rather unselective
SAHA (commercial name ZOLINZA by Merck & Co.) and the
cyclic and disulﬁde bridged romidepsin (commercial name
Istodax by Celgene) have been approved by the US Food and
Drug Administration as ﬁrst-in-class drugs against cutaneous
T-cell lymphoma, via the inhibition of HDACs. There are
currently more than 130 open clinical trials involving HDAC
inhibitory drugs in the treatment of numerous forms of cancer
(Clinical Trials Website 2013). Recent efforts in this area have
become focused on the development of isoform selective
HDAC inhibitors, which are hypothesized to have improved
efﬁcacy and to cause fewer side effects like fatigue, nausea,
dehydration, diarrhea, thrombocytopenia, or electrocardiogram
changes (Marks, 2010).
To enable detailed thermodynamic studies on the interaction
of small organic inhibitors to HDAH, a series of dansyl-
conjugate ligands with alkyl-chains of different length have
been synthesized and used to develop FRET-based binding as-
says for HDAH. The binding data obtained were of excellent
quality and were allowed for the calculation of ΔG0, ΔH0, and
ΔS0 of the binding event. To complement this binding data,
the molecular interactions and the structural ﬂexibility of the
complexes were further investigated using MD simulations.
The selectivity of all ligands was measured in enzyme activity
assays against a panel of recombinant human HDACs. The
association and dissociation kinetics of dansyl-ligand binding
to HDAH were also measured to demonstrate the feasibility of
the described assay for the investigation of fast binding
reactions and getting insight in reaction mechanisms.
MATERIALS AND METHODS
Materials
All chemicals if not stated otherwise were obtained from
Sigma/Aldrich (USA). SAHA was purchased from Cayman
Chemical (USA), and MB275 was prepared according to Fuchter
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et al. (2012) (referring to compound 25 of that publication). The
synthesis including chemical analytics of the six dansyl-
conjugates is described in the supporting information. His-
tagged FB188 HDAH was prepared as described elsewhere
(Hildmann et al., 2004). The assay buffer consisted of 250mM
sodium chloride, 250 μM ethylenediaminetetraacetic acid,
15mM Tris–HCl, 0.001% Pluronic F-127 and 50mM potassium
phosphate at pH 8.0. The buffer components were purchased
from Merck (Germany), Roth (Germany), and Sigma-Aldrich
(USA). DMSO, tris(2-carboxyethyl)phosphine, and trypsin
(bovine pancreas) were purchased from Sigma-Aldrich, and
Boc-Lys(Ac)-AMC and Boc-Lys(triﬂuoacetyl)-AMC from Bachem
(Switzerland). The recombinant human histone deacetylases
were obtained from BPS Bioscience (USA). All reactions were
performed in black half area 96-well microplates (Greiner bio-
one, Germany).
Fluorescence resonance energy transfer-based binding assay
To investigate the direct binding of the dansyl-conjugate
probes 5a–f to HDAH 500 μl of a 0.1 μM HDAH solution in
assay buffer pH 8.0 was ﬁlled in a cuvette and equilibrated
to the desired ﬁnal temperature in a spectroﬂuorimeter
(Hitachi, F-7000). After equilibration, the concentration of
the corresponding dansyl-conjugate was increased succes-
sively by adding small volumes of pre-equilibrated probe
solved in assay buffer. After each addition, the time course
of the FRET signal from the intrinsic tryptophans (donor) of
HDAH to the dansyl moiety (acceptor) of the probe was
measured at an excitation wavelength of 285 nm (slit 5 nm)
and an emission wavelength of 525 nm (slit 10 nm) until the
mean signal changed less than 1% over a period of 60 s. To
determine the contribution of directly excited ligand to the
ﬂuorescence signal at 525 nm, a titration experiment in the
absence of HDAH was performed in parallel. The ﬂuorescence
signal of the corresponding dansyl-conjugate at each con-
centration was substracted from the ﬂuorescence signal of
its mixture with HDAH and then normalized with respect to
maximal binding. The competitive binding assay was
performed as follows. At ﬁrst, a protein–ligand complex was
pre-formed by mixing 1.0 μM 5e and 100 nM HDAH and incu-
bating the mixture at the desired temperature until the mean
FRET signal (ﬂuorescence intensity at 525 nm) remained con-
stant within an error of less than 1% over a period of 60 s.
Then increasing amounts of compounds were added. Again,
it was assumed that chemical equilibrium was achieved when
the change of FRET signal was less than 1%. The contribution
of 5e and the respective compound to the ﬂuorescence
intensity was determined in a parallel titration experiment
in the absence of HDAH, subsequently subtracted from the
ﬂuorescence intensities in the presence of HDAH and normal-
ized as described before in the direct binding mode.
Calculation of binding constant Kd
The dissociation constants, Kd-values, of the dansyl-conjugates
with HDAH were determined from titrations of the protein with
the corresponding conjugate measuring direct binding and
exploiting the change in FRET signal (intensity at 525 nm). The
binding degree, BD, was calculated from the FRET signal, F, of
each data point, which was corrected for background signal
and normalized to the maximal FRET signal, Fmax, and then ﬁtted
to the following model function for ligand binding using
GraphPad Prism (GraphPad Software, USA) revealing the corre-
sponding Kd-value:
BD ¼ F
Fmax
¼ 0:5
E½ 0
L½ 0 þ E½ 0 þ Kd 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
L½ 0 þ E½ 0 þ Kd
 2  4 E½ 0 L½ 0
q 
(3)
where Kd is the dissociation constant, [L]0 is the total concentra-
tion of the respective dansyl conjugate, and [E]0 denotes the
total concentration of HDAH.
The Kd-values of compounds being potential binders to the
protein were determined using the competition binding assay.
In these cases, the dansyl-ligand 5e was used as ﬂuorescent
ligand probe and its dissociation constant, K1, as determined
from direct binding experiments at the respective temperature
was used to calculate the Kd-values of the compounds, K2, by
ﬁtting the data to the following model function using GraphPad
Prism (GraphPad Software, USA):
F
Fmax
¼ 1
2 E½ 0
pþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
p2 þ 4 E½ 0K2 L½ 0
K1
K1
L½ 0 þ 1
 
vuut
0
B@
1
CA; (4)
With
p ¼
K2 þ K1L½ 0 K2 þ I½ 0  E½ 0
 
K1
L½ 0
K1
L½ 0 þ 1
  ;
where the probe concentration, [L]0, was held ﬁx, [E]0 was the
total protein concentration, and [I]0 was the compound con-
centration, which was varied. It is assumed that the free con-
centration of the probe remains unchanged upon binding to
HDAH ([L] = [L]0). This condition is essentially fulﬁlled because
of the 10-fold excess of the probe over HDAH. The derivation
of equation 4 is given in the supporting information. It is to men-
tion that K1 of the starting complex should be in the same order
than the Kd value of the compound to be calculated. Compounds
with Kd<< K1 can only be recognized qualitatively as tight
binders. But a calculation of Kd values is not possible because
of stoichiometric displacement of the probe upon the addition
of increasing amounts of compound. If Kd>> K1, solubility
problems or strong autoﬂuorescence or quenching of test com-
pounds may limit the use of high compound concentrations,
which must be applied to displace the probe from HDAH.
However, although the quantiﬁcation of Kd values is not possible
in cases of extreme Kd/K1 ratios, the compounds can easily be
classiﬁed as strong or weak/non-binders.
Calculation of thermodynamic parameters ΔH0, ΔS0, and ΔG0
The Kd values of a ligand at eight different temperatures from 18
to 37°C were transformed in binding free energy, ΔG0, according
to equation 1. The data of van’t Hoff plots (ΔG0 versus tempera-
ture) were ﬁtted to equation 2 using GraphPad Prism (GraphPad
Software, USA) and yielding the desired changes in enthalpy,
ΔH0, and entropy, ΔS0.
C. MEYNERS ET AL.
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Binding kinetics
All association and dissociation kinetics were followed using a
spectroﬂuorometer (Hitachi, F-7000). Fluorescence was excited
at 285 nm, and the change in ﬂuorescence intensity at 525 nm
was measured as a function of time. The association kinetics of
HDAH and dansyl-ligands were initiated by rapid mixing of both
reactands at the denoted concentrations in assay buffer at 21°C.
To obtain the dissociation rates of the dansyl-ligands, a high
molar excess of 500μM non-ﬂuorescent SAHA was added to a
preformed complex consisting of 200 nM HDAH and one of the
respective dansyl-ligands (12.8μM 5c, 6.4μM 5d, 1.6μM 5e, or
1.6μM 5f) in assay buffer at 21°C, and the corresponding
displacement kinetics were measured as described.
Enzyme activity assays
The inhibitory potential of dansyl-ligands, MB275, and SAHA
against recombinant human HDACs was determined using
ﬂuorogenic enzyme activity assays according to Wegener et al.
(2003). In short, the ligands were pre-incubated with HDAC to al-
low for interaction. The addition of substrate (Boc-Lys(Ac)-AMC
for HDACs 1, 6 and Boc-Lys(triﬂuoracetyl)-AMC for HDACs 4, 8)
started the enzyme reaction. After 60min, the reaction was
stopped, and the deacetylated substrate was converted in a
ﬂuorescent product using trypsin. The released AMC served as
a measure of enzyme activity. In contrast, HDAH assays were
performed in one step by combining the addition of substrate
and trypsin. This became possible because of the insensitivity
of HDAH against trypsin digestion.
Docking and molecular dynamics simulations
Several X-ray structures of HDAH are available (2VCG, 2GH6,
1ZZ0, 1ZZ1, and 1ZZ3). The structure of a complex between
HDAH and SAHA (1ZZ1) was selected because of its high resolu-
tion of 1.57 Å. Accordingly, computational docking studies were
carried out on the dansyl-conjugates 5a–f and all compounds
by using SwissDock (http://www.swissdock.ch/) (Grosdidier et al.,
2011) in the accuratemode and allowing the side chains to be ﬂex-
ible within 5Å of any atom of the corresponding ligand in its refer-
ence binding mode. Docking was performed on the protein
structure (PDB 1ZZ1) in Protein Data Bank (PDB) and the ligand
in Tripos Mol2 format. The best poses of ligand–protein complex
structures were selected for MD-simulations using Gromacs V.
4.0.7.21 (Hess et al., 2008) with an implemented AMBER-99
forceﬁeld (DePaul et al., 2010). The particle mesh Ewald method
was used for the treatments of long-range electrostatic interac-
tions. The enzyme–ligand complexes were subjected to two steps
of energy minimization in vacuo using steepest descent and
conjugate gradient method to remove bad van-der-Waals (vdW)
contacts. Then the protein was solvated in a periodic cubic box
of Tip4 water molecules (Jorgensen and Madura, 1985) containing
Na+ and Cl– ions corresponding to a ﬁnal concentration of 250mM
NaCl, which complied with the salt concentration of the assay
buffer employed. Approximately 35,000 water molecules were
added to each system. After another energy minimization of the
solvated complex position-restrained dynamics simulations were
run to soak the water into the enzyme-ligand complex (200ps at
100 K, 60 ps at 200 K, and 200 ps at 300 K) followed by an equil-
ibration period of unconstrained 2 ns MD-simulation at 300 K.
Finally, two productive MD simulations were performed both
over a period of 20 ns at the same temperature. The trajectory
traces were visualized and analyzed using the program VMD
1.8.7.24 (University of Illinois). Non-polar and polar solvent
accessible surface areas have been calculated for the binding
pocket using the implemented Shrake–Rupley algorithm (Shrake
and Rupley, 1973) and a probe radius of 1.4Å. The binding pocket
was deﬁned to consist of amino acids 21, 98, 100, 140, 142, 143,
151, 152, 153, 180, 182, 207, 208, 268, 275, 309, 310, and 312. In
addition, root mean square ﬂuctuation (RMSF) values as well as
root-mean-square distance curves were calculated in VMD. A
water distribution map was generated by measuring the distance
between each water–oxygen atom and both, the hydroxyl-oxygen
of Y312 and the Cζ-atom of F208 in 2000 snap shots using VMD
and creating two-dimensional histograms by counting the occur-
rence of water oxygen atoms in a two-dimensional distance grid
with 0.1Å bins using MatLab (Mathworks Inc., USA).
RESULTS AND DISCUSSION
Design and synthesis of histone deacetylase like
amidohydrolase probes
For the development of a FRET-based assay, HDAH probes were
designed according to the accepted HDACi pharmacophore
(Zhang et al., 2011) consisting of a zinc-chelating hydroxamate
group, an alkyl spacer with varying chain length and a dansyl
moiety as the capping group. The dansyl moiety was selected
to serve as acceptor dye for the ﬂuorescence of intrinsic tryp-
tophan residues (donor) of HDAH. It was also assumed that the
relatively small aromatic dansyl moiety, which contained a
sulphonamide linkage to the binding moiety would be a suitable
substitute for an aromatic capping group, a key feature of many
inhibitors of HDAH and other HDACs (Riester et al., 2007; Riester
et al., 2009). The synthesis of the dansyl-hydroxamic acid conju-
gates was straightforward (Figure 1). Condensation between
the commercially available dansyl chloride 1 and aminoacids
2a–f under basic conditions afforded sulphonamides 3a–f in good
to excellent yield (58–85%). Further EDCI mediated coupling with
benzylhydroxylamine afforded hydroxamic acid precursors 4a–f in
moderate to excellent yield (48–92%). Final hydrogenolysis of the
benzyl protecting group afforded dansyl-conjugate probes 5a–f in
57–85% yields. See the supporting infomation for detailed reac-
tion conditions and analytical data.
Isothermal binding of dansyl-conjugates and
non-ﬂuorescent inhibitors to histone deacetylase
like amidohydrolase
Binding of the dansyl-conjugates to HDAH resulted in a pro-
nounced FRET from intrinsic tryptophan residues of the protein
to the chromophore moiety of the dansyl-ligand probes. This
was clearly indicated by a decrease of the tryptophan emission
and a simultaneous increase in dansyl ﬂuorescence intensity
(Figure 2). The increase in ﬂuorescence intensity at 525 nm was
exploited to obtain binding isotherms at eight different temper-
atures between 18 and 37°C with a precision of ±0.1°C. The
dansyl-conjugate 5f with highest afﬁnity was used to determine
the binding stoichiometry in a titration using concentrations
much higher than the corresponding Kd value of 60 nM. The ratio
between 5f and HDAH was proven to be 1:1 (Figure S5). The
same stoichiometry was assumed for complexes between HDAH
and the other ligands with similar structure. Dansyl-conjugates
5a and 5b only exhibited weak binding to HDAH. Ligand 5b
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bound to HDAH with a dissociation binding constant, Kd, above
20μM, whereas binding of 5a was not detectable up to concen-
trations of 50μM. The weak interactions observed for ligands 5a
and 5b were probably caused by the short spacer length of n= 2
and 3 between the metal ion chelating hydroxamate group and
the bulky dansyl residue, which hampered the access of the li-
gand to the bottom of the binding pocket due to sterical hin-
drance thereby interfering with the key electrostatic interaction
between the zinc cation at the base of the active site pocket
and the zinc-binding hydroxamate functionality of the ligand.
Dansyl-conjugates 5c–5f bound to HDAH with increasing afﬁnity
down to a Kd value of 60 ± 7 nM for 5f at 25°C (Figure 3). Many
HDAC inhibitors have been reported that consist of a
hydroxamic acid and a ﬁve-carbon or six-carbon hydrophobic
linear spacer attached to an aromatic surface recognition motif
(Paris et al., 2008). This general design criterion is conﬁrmed by
our series of dansyl-ligands with afﬁnity increasing for linkers
extending from two to seven-carbon units. Binding of 5c–5f to
HDAH was reversible as shown by the displacement of the
dansyl-ligands with SAHA, which effectively competed for bind-
ing in the active site of the enzyme. Such competitive binding
allowed the use of these ﬂuorescent ligands in further competi-
tive binding experiments with known inhibitory compounds.
The drug SAHA and the known HDACi MB275 were chosen as
test compounds. We previously reported the synthesis and
HDAC inhibiting features of MB275, which is a hybrid compound
of the natural product HDAC inhibitor psammaplin A (Baud et al.,
2012). Binding constants of both non-ﬂuorescent inhibitors were
determined from competitive titration experiments where the
compound was titrated into a pre-formed complex consisting
of dansyl-ligand probe 5e and HDAH (Figure 4). We determined
Figure 1. Synthesis scheme of dansyl-conjugate probes for HDAH.
Figure 2. Fluorescence resonance energy transfer between HDAH and
5d. Titration of 100 nM HDAH in assay buffer with increasing concentra-
tions of 5d ranging from 12.5 nM to 12.8μM at 25°C. The samples were
excited at 285nm, and the emission spectra corrected for contributions
of direct excitation of the ligand. The ﬂuorescence emission intensity
was plotted versus wavelength. The signal at about 350 nm decreased,
and the emission at about 525 nm increased upon binding of 5d to
HDAH, which was indicative for ﬂuorescence resonance energy transfer.
The perturbation at about 570 nm was due to a suboptimal correction
of second order diffraction at the excitation grating monochromator.
Figure 3. Binding isotherms of dansyl ligands 5c–f to HDAH. Binding
degrees were plotted versus the respective ligand concentration as indi-
cated. Indicated concentrations of 5c–f were added to 100nM HDAH in
assay buffer at 25°C. The binding degree was calculated from the change
in FRET signal upon binding as described in the method section. All data
points represent means of triplicates. The standard errors are displayed
as error bars. The data were ﬁt to a one-site binding model considering
ligand depletion (equation 3) as described in the experimental section.
The calculated Kd values are summarized in Table 1.
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exemplarily Kd values of both inhibitors at eight different
temperatures to demonstrate that thermodynamic parameters
could also be obtained from the temperature dependency of
Kd as calculated from indirect competitive binding assays. The
binding constant obtained for SAHA, Kd=0.96 ± 0.01μM, is in
good agreement with 1.0μM as determined by a recently
reported FRET-assay exploiting a furylacryloyl group as an
acceptor chromophor that does not emit ﬂuorescence (Riester
et al., 2007) and 0.77μM, which was obtained from a combined
fluorescence polarization and lifetime-based binding assay
(Riester et al., 2009).
The robustness and performance of the FRET-assay in high-
throughput applications were also demonstrated using microti-
ter plates (Figure S6). The performance of the high throughput
screening (HTS) assay was calculated according to Zhang et al.
(1999). For the FRET-based binding assay, excellent performance
was proven by z’-values between 0.72 and 0.82. We achieved a
manual throughput of 96 compounds in about 50min. The limit-
ing step was a 30-min incubation of the preformed protein–ligand
complex and the screening compounds to reach chemical equilib-
rium. Using specialized robotic equipment and more dense plate
formats a much higher throughput will be possible.
Thermodynamic signatures and selectivity of histone
deacetylase like amidohydrolase ligands
Van’t Hoff plots of dansyl-conjugate ligands 5c–f and inhibitors
SAHA and MB275 are shown in Figure 5. All data showed a linear
relationship between ΔG0 and T and negative slope indicating
an increase in entropy upon binding of ligands to HDAH. The
enthalpic and entropic contributions are presented in Figure 6.
The relatively weak binding of 5c to HDAH is clearly entropically
driven as indicated by a distinct positive binding enthalpy.
Figure 4. Competitive displacement of 5e from HDAH. Binding degrees
calculated from FRET signals were plotted against the concentration of
non-ﬂuorescent HDAH inhibitors. 1 mikromolar (μM) 5e and 100nM HDAH
were mixed to pre-form about 80% of its complex with HDAH in assay
buffer. Subsequently, different concentrations of SAHA and MB275 were
added. Each data point represents the mean of triplicates. Error bars
indicate the standard error. In most cases, the error becomes so small that
error bars are indistinguishable from corresponding data points. The data
were ﬁtted to a competitive binding model (equation 4) as described in
the experimental section. The Kd values of SAHA and MB275 were
calculated to be 0.96± 0.01 and 2.1 ±0.2μM, respectively.
Figure 5. Van’t Hoff plots of ligand binding to HDAH. Free binding energy, ΔG0, derived from equilibrium titrations involving indicated compounds
were plotted versus temperature. The data were ﬁtted to the expression in equation 2 yielding ΔH0 and ΔS0.
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Increasing the length of the linker yields not only stronger bind-
ing but also a shift to enhanced enthalpic contribution to the
recognition of HDAH and ligand. On the other hand, the binding
afﬁnity and the ΔH0/ΔG0 ratio are not perfectly correlated. Even
though 5f showed a 5-time lower Kd-value than 5e, 5e turned
out to feature the highest enthalpy contribution to the free
energy of binding. Interestingly, the binding of the approved
drug SAHA to HDAH was entropically driven with a small but
signiﬁcant unfavorable positive binding enthalpy. In contrast,
the derivative of psammaplin A, MB275, showed a similar afﬁnity
but a much higher enthalpic contribution to binding. The
importance of favorable ΔH0 is highlighted by several authors
(Freire, 2008; Ladbury et al., 2009). It is postulated that favorable
enthalpic contributions reﬂect optimal geometries in non-
covalent interactions particularly hydrogen-bonds and vdW
interactions. The optimal molecular recognition is achieved, if
all polar atoms of the binding site are satisﬁed with polar part-
ners of the ligand having all H-Bonds formed perfectly directed
at optimal distances and vdW forces are maximized by a perfect
geometric ﬁt between protein and ligand. Favorable entropic
terms arise mainly from desolvation effects or a net increase in
mobility of the binding partners. Maximal selectivity can be
achieved, if few strong H-bonds with deﬁned angles and
interatomar distances, which are indicated by a favorable
enthalpic contribution, toward unique sites in a target protein
are formed, which are not possible in off-target molecules. On
the other hand, the major entropic contribution to binding
afﬁnity often results from the hydrophobic effect, which is asso-
ciated with positive binding entropy and represents the exclu-
sion of solvent molecules rather than a directed attractive force
between protein and ligand. Therefore, entropic contributions
to binding afﬁnity are usually non-selective in nature. In addition,
conformationally constrained inhibitors with perfect shape
complementarity to a binding pocket will have better binding
afﬁnities and also selectivities than their ﬂexible derivatives
because of a reduced loss of conformational entropy and
therefore a greater enthalpic contribution to binding. While the
optimization of ΔH0 does not necessarily increase ligand afﬁnity
due to enthalpy–entropy compensation, it is supposed to in-
crease selectivity due to the spatial and electrostatic require-
ments at the protein–ligand interaction surface (Chaires, 2008;
Kawasaki and Freire, 2011). In addition, Ohtaka and Freire ob-
served that HIV-protease inhibitors, which established strong
enthalpic (H-bonds and vdW) interactions with conserved re-
gions of the target protein and contained ﬂexible functionalities,
achieved high adaptability to mutant proteins while maintaining
selectivity against off-target proteins (Ohtaka and Freire, 2005).
To analyze the relationship between enthalpic contribution and
selectivity, the capability of all ligands to inhibit representatives
of human HDAC classes I and II was investigated using enzyme
activity assays as described in the method section. The resulting
IC50-values are summarized in Table 1. The series of dansyl-
ligands that are characterized by the same Zn2+-chelating
hydroxamate and dansyl-head group and only differ in the
length of the alkyl linker was analyzed in more detail. Ratios of
IC50-values served as a measure for selectivity in terms of
enzyme inhibition and were correlated with the enthalpic contri-
bution to free energy of binding, ΔH0/ΔG0 (Figure 7). HDAH is a
close homologue of HDAC6 and therefore belongs to HDAC class
IIb. The data in Figure 7 highlight the clear correlation between
selectivity against HDAC1 as a representative of HDAC class I
and the ΔH0/ΔG0 ratio. 5e achieves a ratio of 0.29, which is in
agreement with Ruben et al. (2006), who reported that the
optimal enthalpic contribution to binding is about one-third for
the interaction between allophenylnorstatine inhibitors and
plasmepsin II. However, the optimal enthalpy–entropy balance
in molecular recognition between protein and ligands is sup-
posed to be dependent on the chemistry and geometry of the
binding site. In contrast to the increase in selectivity against
Figure 6. Thermodynamic signatures of HDAH ligands at 295 K.
Table 1. Binding constants and IC50 values against histone deacetylase like amidohydrolase and histone deacetylase enzymes
Ligand n IC50/μM HDAH IC50/μM HDAC1 IC50/μMHDAC4 IC50/μM HDAC6 IC50/μM HDAC8 Kd/μM HDAH
5a 2 7.8 ± 0.2 >50 >100 >100 6.7 ± 1.9 >50
5b 3 0.97 ± 0.18 2.0 ± 0.2 86 ± 24 3.1 ± 0.3 2.4 ± 0.8 >20
5c 4 0.30 ± 0.02 0.18 ± 0.05 59 ± 7 0.41 ± 0.04 1.8 ± 0.3 5.4 ± 0.7
5d 5 0.08 ± 0.01 0.13 ± 0.02 28 ± 2 0.39 ± 0.04 0.68 ± 0.10 0.96 ± 0.05
5e 6 0.060 ± 0.002 0.19 ± 0.04 10 ± 1 0.22 ± 0.05 0.32 ± 0.04 0.30 ± 0.02
5f 7 0.056 ± 0.002 0.17 ± 0.02 5.0 ± 0.2 0.080 ± 0.010 0.23 ± 0.02 0.060 ± 0.007
SAHA — 0.063 ± 0.002 0.017 ± 0.001 >50 0.046 ± 0.002 1.4 ± 0.1 0.96 ± 0.01
MB275 — 0.060 ± 0.001 0.34 ± 0.01 >100 2.4 ± 0.1 9.3 ± 0.5 2.1 ± 0.2
Compounds were tested in enzyme activity assays under conditions described in the method section. Mean values and standard
errors were calculated from ﬁts to sets of 10 different concentrations for each ligand and compound.
HDAH, histone deacetylase like amidohydrolase; HDAC, histone deacetylase; SAHA, suberoylanilide hydroxamic acid.
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HDAC1, the selectivity against the closest human homologue,
HDAC6, could not be improved. This ﬁnding underlines the
sequential and structural similarities within the same HDAC class,
which does not provide a good starting point for selectivity
improvements between class members. Furthermore, there is
only a slight but not signiﬁcant increase in selectivity against
HDAC8 with higher contribution of ΔH to binding. This could
be explained by the fact that HDAC8 is the most distant member
of class I HDACs and also shows features of class II HDACs.
Among others, the substrate Boc-Lys(triﬂuoacetyl)-AMC is
converted by class II enzyme HDAC4 and HDAC8, but not by
HDAC1; on the other hand, the unﬂuorinated derivative is an
excellent substrate of HDAC1 but not of HDAC4 and HDAC8.
The ambivalent functional characteristics and structural features
of HDAC8 make it more difﬁcult to achieve selectivity improve-
ments regarding the inhibition of HDAH and HDAC8. There is
already a big selectivity difference between the inhibition of
HDAC4 and all other enzymes. This is attributed to the unique
substitution of the tyrosine (Y312 in HDAH) in the catalytic center
by histidine in human class IIa HDACs, which causes a dramatic
loss in afﬁnity for many hydroxamate-based inhibitors, including
the rather unselective so-called pan-inhibitor SAHA and MB275.
In the light of the distinct molecular differences of the binding
pockets and the ensuing tremendous selectivity of all investi-
gated ligands against HDAC4, no further improvement could
be achieved. Altogether, the data are consistent with the classi-
ﬁcation of HDACs and underline the suitability of thermody-
namic signatures as guidance for the optimization of the
selectivity of inhibitors.
Molecular dynamics simulations
Because proteins are ﬂexible and supposed to undergo more or
less pronounced conformational changes and induced ﬁt upon
ligand binding, docking and MD simulations were performed
to obtain a dynamic view on the HDAH-ligand complexes and
the involved distinct intermolecular interactions. The compu-
tational analysis of the MD simulations allowed the interpreta-
tion of the thermodynamic data in terms of the structural and
dynamic information on the complexes. The electrostatic interac-
tion between the hydroxamate group of the ligands and the
catalytic Zn2+ ion, hydrogen bonds to mainly Y312 and H142
as well as vdW interactions are the main determinants of recog-
nition that govern the binding enthalpy of ligand binding to
HDAH. For a molecular interpretation of the experimental
thermodynamic parameters, the X-ray structure of the complex
between HDAH and SAHA (PDB 1ZZ1) was used to dock all inves-
tigated ligands to HDAH. The complexes were energetically min-
imized and subjected to MD simulations in water environment
with adapted NaCl concentration to analyze the dynamics of
the elementary molecular interactions in more detail. Besides
ﬂuctuation information and evidence for structural water, the
analysis revealed the number of ligand-Zn2+contacts, percent-
ages of H-bonds, and the mean number of vdW contacts over
the whole time range of simulations (Table 2). The resulting data
suggest that the dansyl-ligands 5d–5f as well as SAHA and
MB275 form bi-dentate complexes with the Zn2+ ion at the
bottom of the active site thereby effectively shielding the metal
ion from solvent water molecules (Figure 8 A and 8C). All ligands,
even the weak micromolar binders, tighten the binding pocket
signiﬁcantly causing entropic losses. The dansyl ligands with
highest afﬁnity to HDAH, 5f and 5e, displayed strong favorable
changes in binding enthalpy, 5.7± 2.9 and 10.5 ± 2.3 kJmol1,
respectively. This correlated with the highest mean number of
vdW contacts, two contacts to Zn2+, and high percentage of
H-bonds to Y312 or H142. 5e showed a distinct low residual
mobility and also reduced the RMSF of the ﬂexible loop (90–104)
strongest which agrees with the lowest favorable binding entropy.
Compared with 5e, the residual ﬂexibility of the ligand and loop
(90–104) in the complex between 5f and HDAH was increased,
Figure 7. Relationship between selective inhibition and thermodynamic signatures. The ratio of IC50-values against HDAH and different HDACs is con-
sidered as a measure of selective enzyme inhibition and plotted versus the ratio ΔH0/ΔG0. The Pearson coefﬁcient r indicates the correlation between
selectivity versus the respective human HDAC and the enthalpic contribution to binding. The relationship is signiﬁcant, if the p-values< 0.05.
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which is attributed to the long spacer and enhanced ﬂuctuation of
the only weakly constrained dansyl head group. Consequently, the
entropic penalty was signiﬁcantly reduced, while the enthalpic
contribution was only slightly decreased yielding a higher afﬁnity
than 5e. Dansyl-ligand 5d showed a slightly positive binding
enthalpy, which is compensated by a favorable binding entropy
indicating a loss of strong speciﬁc interactions. The positive ΔH0
corresponds mainly to a decrease in vdW contacts to the aromatic
side chains of F208 and F152. The loss in vdW contacts accounts for
an increased remaining mobility of the ligand, which is supposed
to increase the corresponding binding entropy. In addition, bind-
ing of 5d did not tighten the ﬂexible loop (90–104) thereby further
raising ΔS0 with respect to 5e and 5f. The clearly decreased afﬁnity
of 5c is characterized by a largely unfavorable binding enthalpy
and a large compensating positive binding entropy. The dramatic
enthalpic loss agrees with the ability of 5c to form only a mono-
dentate complex with Zn2+, which is accompanied by a further loss
of hydrogen-bonding to Y312, which is a very important determi-
nant of inhibitor binding to HDAH in X-Ray structures (PDB 1ZZ1,
1ZZ3, and 2VCG). This weak coordination is relevant to the limited
water access to the binding pocket. In Figure 8C, the water distri-
bution within the binding pocket of free HDAH and all investigated
ligand–protein complexes is shown. The distribution maps repre-
sent the density of water molecules at positions with indicated
distances to the oxygen atom of the hydroxyl group of Y312 at
the bottom and the aromatic Cζ atom of F208 at the rim of the
Figure 8. Molecular dynamics simulation of dansyl-ligand complexes with HDAH. A, overlay of a series of snapshots of dansyl-ligands 5c–f in the active
site of HDAH. The different colors of the corresponding ligands indicate snapshots at different simulation times (11–20 ns in 1 ns steps) and illustrate the
ﬂexibility of the ligand within the binding pocket; B, structural water molecules within the binding pocket of the complex between 5c and HDAH.
Purple lines between water molecules and protein or ligand represent hydrogen bonds. C, water distribution within the binding pocket of HDAH,
unbound or in complex with indicated ligands. Data are from 2000 snap shots of MD simulation for each system.
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active site. The distribution patterns reveal that water molecules
are largely displaced upon ligand binding, as expected. On the
other hand, different ligands cause differential water distribution
patterns, which could be attributed partially to the space-ﬁlling
properties of the ligands but also to the adaptation of the binding
pocket to the respective ligand. It is also striking to see two distinct
small well-deﬁned areas of high solvent density within the binding
pocket of dansyl-ligand 5c, which cannot be seen with all other
ligands (Figure 8C). Similar but less sharply contoured areas of
higher solvent density near Y312(OH) in the binding pockets of
5d or MB275 represent water molecules that only occupy this
space for short timescales, being long-term exchanged for alter-
native water molecules. The two spots with increased solvent
density in the solvent distribution map of the 5c/HDAH complex
represent two water molecules that are trapped at certain
positions within the binding pocket and can effectively be
regarded as structural water molecules held in place by hydro-
gen-bonding throughout a time range of 40 ns MD simulation
at 300 K (Figure 8B and Figure S3). The ﬁrst structural water
molecule bridges HDAH and ligand through hydrogen-bonds
between the hydroxyl-oxygen of Y312 and the carbonyl-oxygen
of 5c thereby stabilizing the mono-dentate electrostatic interac-
tion between 5c and Zn2+. The water molecule has a mean
distance of 2.8 Å to the hydroxyl-oxygen (OH) of Y312 and
11 Å to the Cζ atom of F208. The second spatially constrained
water molecule is hydrogen-bonded by D273 and D268 with a
mean distance of 6.9 Å to both Y312(OH) and F208(Cζ). The
deﬁcit in speciﬁc interactions correlates with overall increased
RMSF values indicating higher ﬂexibility. The afﬁnity of SAHA
and MB275 is rather similar to dansyl-ligand 5d as is the
chelation of Zn2+ and the mean number of vdW-contacts. At
the same time, binding to HDAH appears more entropy driven
for 5d and SAHA than for MB275 at 25°C. These disparities are
hard to interpret because of larger differences in the chemical
structures of the respective ligands, which differ more signiﬁ-
cantly than only in the length of the spacer. Hydrophobic inter-
action of the dansyl-ring of 5d with hydrophobic amino acid
side chains and release of solvated water molecules is a poten-
tial source for a more positive ΔS0.
In general, the enthalpy/entropy balance is understood to de-
pend on many system-speciﬁc properties (Bissantz et al., 2010)
but is still accepted as an important factor for optimizing the
selectivity of drugs and avoiding side effects (Kawasaki and
Freire, 2011) thus aiding the decision about which compound
to take forward in the drug development process. If several com-
pounds are available with similar binding constants but different
thermodynamic signatures, as is the case with 5d, SAHA, and
MB275, a greater enthalpic contribution to binding is supposed
to be more beneﬁcial in terms of selective recognition.
Association and dissociation kinetics of dansyl-ligands and
histone deacetylase like amidohydrolase
It is not only of interest to analyze a ligand–protein system at
chemical equilibrium but rather to also investigate its kinetic
behavior. The investigation of association and dissociation
kinetics provides more detailed information about catalytic
intermediates and reaction mechanisms. Moreover, the
determination of rate constants of elementary compound-
target protein reaction steps will provide valuable additional
information for the assessment of potential drug candidates.
In this study, we demonstrate the general applicability of
the FRET-based binding assay to the measurement of binding
kinetics. For dansyl-ligands 5c–f, both association and
dissociation kinetics could be measured (Figure 9 Figure S2).
The dissociation rate constants of 5c, 5d, 5e, and 5f
decreased with increasing spacer length and were deter-
mined to be (15.6 ± 0.1) × 103 s1, (5.0 ± 0.02) × 103 s1,
(4.0 ± 0.01) × 103 s1, and (0.9 ± 0.004) × 103 s1 at 21°C, re-
spectively. Further studies with varying concentrations of
these dansyl-ligands are ongoing to elucidate the respective
binding mechanism to HDAH in more detail.
Usually, the kinetics of binding reactions are investigated by
mixing both reaction partners and measuring the change of an
optical signal indicating the progression of complex formation
as was demonstrated for aforementioned dansyl-ligands and
HDAH. However, it would be even more interesting to investi-
gate the binding kinetics of potential drugs to HDAH, if no
optical change could be observed upon complex formation. In
principle, a variant of the described homogeneous FRET-based
binding assay should also be applicable to the indirect dissection
of such drug-HDAH binding kinetics through the observation of
the concurrent displacement of the dansyl-ligand probe. An
Figure 9. Association and dissociation kinetics of 5e binding to HDAH.
A, association kinetics of 200 nM HDAH and 1.6μM 5e in assay buffer.
B, dissociation kinetics of pre-formed complex in the reaction of panel
A initiated by the addition of 500μM SAHA. The ﬁrst 4 s of the kinetics
were missing because of mixing artifacts. All reactions were performed
in assay buffer at 21°C. Fluorescence was excited at 285 nm, and the
change in ﬂuorescence intensity at 525 nm (ΔRFU) was plotted versus
time. The smooth dark gray lines represent non-linear regression ﬁts to
mono-exponential functions.
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important prerequisite for such an experimental setup is that the
dissociation of the ligand-probe, in our case the dansyl-ligand,
from its complex with HDAH is not the rate limiting step (see,
e.g., Neumann et al., 2011). A glance at the dissociation rates of
the dansyl-ligand probes revealed that 5c showed the fastest
dissociation behavior and could be used to measure association
and dissociation rate constants of any non-ﬂuorescent com-
pound at conditions where its binding to HDAH occurs much
slower than the dissociation of the probe.
CONCLUSIONS
A homogeneous competitive FRET-based binding assay was
developed to determine thermodynamic parameters for the
binding of dansyl-ligands and non-ﬂuorescent compounds of
interest like SAHA to HDAH, using the van’t Hoff approach. In
contrast to micro-calorimetric studies, the presented assay
format enables a high-throughput analysis of larger numbers of
hit compounds from pharmaceutical screening campaigns on
microtiter plates with extremely low consumption of target
protein, ligand-probe, and compound. The fast readout of the
assay can also be used for further detailed mechanistic studies
of binding kinetics, even on millisecond time scales. Moreover,
the assay principle should be transferable to human recombi-
nant HDACs, which are known to be inhibited by SAHA,
allowing the determination of thermodynamic signatures for
inhibitors of this important class of cancer targets. X-ray struc-
tures of HDAH complexes with several hydroxamate ligands
as well as docking and MD simulations suggest a bi-dentate
coulombic interaction between the dansyl-ligand probes and
the Zn2+ ion at the bottom of the active site, if the ligands
contain alkyl spacer with more than four carbon atoms.
Dansyl-ligand 5c with a 4-carbon alkyl-spacer was only able to
form a mono-dentate complex with the Zn2+ ion. Although
the afﬁnity increased for dansyl-ligands with increasing length
of the alkyl spacer, the maximal enthalpic contribution to the
free energy of binding of 29% was observed with the
dansyl-ligand containing a hexyl spacer. The binding data of
dansyl-ligands to HDAH clearly demonstrated a positive correla-
tion between the ΔH0/ΔG0 ratio and selectivity against HDAC1
as representative of class I HDACs, whereas no improved
selectivity was observed against enzymes out of the same HDAC
class as HDAH. This observation suggests that thermodynamic
signatures can be used to guide the optimization of selectivity
within a series of structurally related inhibitors. Therefore, we
are convinced that thermodynamic signatures are supposed to
provide additional particularly meaningful parameters for the
selection of drug candidates with presumably reduced risk to
fail in subsequent more expensive clinical phases.
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